These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 27664516

  • 1. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z, Cheng J, Liu Q, Zhou L, Kenny J, Wang T, Lin X, Yuan J, Quinn JMW, Tickner J, Hong G, Qin A, Zhao J, Xu J.
    Mol Cell Endocrinol; 2017 Jan 05; 439():369-378. PubMed ID: 27664516
    [Abstract] [Full Text] [Related]

  • 2. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity.
    Ang ES, Pavlos NJ, Chai LY, Qi M, Cheng TS, Steer JH, Joyce DA, Zheng MH, Xu J.
    J Cell Physiol; 2009 Dec 05; 221(3):642-9. PubMed ID: 19681045
    [Abstract] [Full Text] [Related]

  • 3. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 05; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 4. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
    Han SY, Lee KH, Kim YK.
    Int J Mol Med; 2018 Jul 05; 42(1):331-345. PubMed ID: 29620250
    [Abstract] [Full Text] [Related]

  • 5. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F, Liu J, Wang C, Yuan Z, Bi L, Liang J, Su K, Qiu Y, Song T, Fan J, Chao G.
    Biomed Pharmacother; 2017 Aug 05; 92():927-934. PubMed ID: 28605877
    [Abstract] [Full Text] [Related]

  • 6. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G, Zhou L, Shi X, He W, Wang H, Wei Q, Chen P, Qi L, Tickner J, Lin L, Xu J.
    Int J Mol Sci; 2017 Jan 19; 18(1):. PubMed ID: 28106828
    [Abstract] [Full Text] [Related]

  • 7. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
    Kim JL, Kang MK, Gong JH, Park SH, Han SY, Kang YH.
    Mol Nutr Food Res; 2012 Aug 19; 56(8):1223-33. PubMed ID: 22700286
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M, Shan J, Xu H, Xia G, Xu Q, Quan K, Liu X, Dai M.
    J Ethnopharmacol; 2021 Aug 10; 276():114176. PubMed ID: 33933570
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.
    Guan H, Zhao L, Cao H, Chen A, Xiao J.
    FASEB J; 2015 Mar 10; 29(3):1092-101. PubMed ID: 25466887
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
    Hong G, Chen Z, Han X, Zhou L, Pang F, Wu R, Shen Y, He X, Hong Z, Li Z, He W, Wei Q.
    Clin Transl Med; 2021 May 10; 11(5):e392. PubMed ID: 34047464
    [Abstract] [Full Text] [Related]

  • 15. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G, Xu Q, Dai M, Liu X.
    Biochem Biophys Res Commun; 2019 Feb 05; 509(2):329-334. PubMed ID: 30579598
    [Abstract] [Full Text] [Related]

  • 16. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
    Liu C, Guan H, Cai C, Li F, Xiao J.
    Exp Cell Res; 2017 Mar 15; 352(2):293-303. PubMed ID: 28209487
    [Abstract] [Full Text] [Related]

  • 17. Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling.
    Liu C, Cao Z, Zhang W, Tickner J, Qiu H, Wang C, Chen K, Wang Z, Tan R, Dong S, Xu J.
    J Cell Physiol; 2018 Nov 15; 233(11):8971-8983. PubMed ID: 29904917
    [Abstract] [Full Text] [Related]

  • 18. Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption.
    Zhang Y, Li Q, Li X, Wan HY, Wong MS.
    Br J Nutr; 2010 Oct 15; 104(7):965-71. PubMed ID: 20487580
    [Abstract] [Full Text] [Related]

  • 19. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L, Zhou K, Wang S, Zhang H, Fan N, Li J, Tan X, Hu L, Fan X.
    Cell Physiol Biochem; 2018 Oct 15; 48(5):2123-2133. PubMed ID: 30110702
    [Abstract] [Full Text] [Related]

  • 20. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
    J Cell Physiol; 2009 Dec 15; 221(3):618-28. PubMed ID: 19653230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.